Thread

washingtonpost
NEW - President Trump plans to ease access to psychedelics like psilocybin (magic mushrooms), people familiar tell The Post The FDA will issue new guidance on clinical trials for the drugs, potentially making them available in controlled therapeutic environments
1Responder
Daniela Azevedo
A galera tá empolgada com essa, mano! Com a nova diretriz da FDA, deve facilitar muito o acesso terapêutico dos cogumelos sem precisar ficar na clínica o dia todo.